Recent development and potential use of µ- and κ-opioid receptor ligands in positron emission tomography studies
✍ Scribed by Gjermund Henriksen; Frode Willoch; Peter S. Talbot; Hans-Jürgen Wester
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 364 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Quantitative non‐invasive imaging of target structures in the human central nervous system provided by positron emission tomography (PET) permits investigation of the relationship between molecular events and pharmacological effects in living humans. Due to their prominent role in opiate and stimulant drug misuse and dependence, as well as in nociceptive signaling, µ‐ and κ‐opioid receptors are potential targets for advances in neuro(psycho)pharmacological treatment of these illnesses and syndromes. In this review, we describe recent developments in specific positron emitting radiopharmaceuticals for these opioid receptor subclasses. Implications for further advances and clinical applications of the labeled ligands are discussed. Drug Dev. Res. 67:890–904, 2006. © 2007 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Tf, transferrin; TfR, transferrin receptor; [ 18 F]Tf, [ 18 F]-labeled human holo-transferrin; PET, positron emission tomography; [ 18 F]Alb, [ 18 F]-labeled baboon albu-axial resolution 6 mm) in 3-dimensional mode (septa out). Correct min; ROI, region of interest; TAC, time activity curve. position
The goal of the present set of studies was to characterize the in vitro binding properties and in vivo tissue kinetics for the vesicular acetylcholine transporter (VAcChT) radiotracer, [ 18 F](1)-4-fluorobenzyltrozamicol ([ 18 F](1)-FBT). In vitro binding studies were conducted in order to determine
The __N__‐methyl‐ d‐aspartate (NMDA) receptor as a type of ionotropic glutamatergic receptors is essential for physiological processes such as learning, memory and synaptic plasticity. A glutamate‐induced overactivation of these receptors, accompanied by increased intracellular calcium concentration
## Abstract ## BACKGROUND. This study was designed to investigate the fluorine‐18 fluorodeoxyglucose (FDG)‐positron emission tomography (PET) imaging characteristics of triple‐negative (estrogen receptor‐negative [ER−]/progesterone receptor‐negative [PR−]/HER2‐negative [HER2−]) breast carcinoma an
## Abstract We used [^11^C]raclopride (RACLO) and positron emission tomography (PET) to study longitudinally striatal dopamine D~2~ receptor binding in nine patients with Parkinson's disease (PD) at an early drug‐naive stage and 3–5 years later, when motor fluctuations had appeared in seven of them